FDA Grants Abbreviated Approval for Metformin Hydrochloride by AlignScience Pharma
The FDA has granted abbreviated approval for Metformin Hydrochloride (ANDA209303) submitted by AlignScience Pharma.
Company
Pharmaceutical intelligence for AlignScience Pharma with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.